WO1997032542A1 - Female incontinence device - Google Patents

Female incontinence device Download PDF

Info

Publication number
WO1997032542A1
WO1997032542A1 PCT/US1997/003401 US9703401W WO9732542A1 WO 1997032542 A1 WO1997032542 A1 WO 1997032542A1 US 9703401 W US9703401 W US 9703401W WO 9732542 A1 WO9732542 A1 WO 9732542A1
Authority
WO
WIPO (PCT)
Prior art keywords
female incontinence
incontinence device
urethra
forming material
gel forming
Prior art date
Application number
PCT/US1997/003401
Other languages
French (fr)
Inventor
Malcolm D. Heaven
Original Assignee
Urohealth Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urohealth Systems, Inc. filed Critical Urohealth Systems, Inc.
Publication of WO1997032542A1 publication Critical patent/WO1997032542A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0009Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse placed in or outside the body opening close to the surface of the body

Definitions

  • the present invention relates to an improved device for controlling leakage of urine in an incontinent female, and more particularly, to valved catheters and plugs for use in controlling female incontinence.
  • the urinary tract system aids the body in ridding itself of waste.
  • the kidneys process blood at a high rate and filter waste products from the circulatory system, creating urine to remove the waste.
  • the ureters drain urine from the kidneys into the bladder, which serves as a reservoir until urination.
  • the bladder has a storage capacity which ranges from approximately one-quarter to one-half liter.
  • the urinary sphincter is a muscle at the base of the bladder which surrounds the bladder neck and urethra and aids the bladder in maintaining continence.
  • the urethra is the tube through which urine flows when the bladder empties.
  • bladder neck and the urinary sphincter work in a coordinated fashion to act as a valve.
  • the urethra and urinary sphincter muscles relax and open, the bladder contracts and the bladder neck opens, all in a coordinated fashion, causing the passage of urine.
  • the bladder neck opens involuntarily in response to intra-abdominal pressure, the lower portion of the urinary sphincter tightens in turn to maintain continence.
  • the urethra is also under muscular control to keep this tube closed during the urine storage phase.
  • a malfunction in any part of this system can cause urinary incontinence (UI) or loss of urine.
  • UI urinary incontinence
  • the most common anatomic incontinence pathology is bladder neck or urethra hypermobility, which results from a lack of bladder neck support caused primarily by weak surrounding tissue.
  • the weakening of tissue surrounding the bladder, urethra and bladder neck arises most commonly in women as a consequence of pelvic trauma caused by pregnancy and childbirth.
  • Other causes of incontinence include physiological, anatomical and neurological disorders.
  • UI sufferers there are approximately 10 million UI sufferers in the United States, of which it is estimated that approximately 85% are women.
  • the total worldwide population suffering with UI for developed countries is approximately 22 million women.
  • UI afflicts women of all ages, primarily those over 40, and tends to get worse over time. Women have short urethras and hence less occlusive force. More importantly, women suffer significant pelvic trauma during pregnancy and childbirth. In pregnancy and childbirth, a woman's pelvic nerves and muscles are stretched to a great degree and, as a result, the continence function is often impaired. Therefore, UI shows an increase in incidence as a function of the number of children born to a woman.
  • Urinary plugs generally are disposable devices.
  • An example of such a device includes a shaft with one or two integral balls thereon. When inserted in the urethra the ball(s) occludes the urethra and holds the device in place until such time as the patient wishes to void, whereupon the plug is physically removed in order to allow urine to flow.
  • a device is manufactured by PharmaPlast of Denmark.
  • Another plug type device manufactured by Uromed Corporation, uses an inflated balloon to retain the device in place. This type of device is disclosed in U.S. Patent No. 5,090,424 to Simon et al. and in WO94/26215 to McLaughlin et al.
  • Another similar plug type device is manufactured by Rochester Medical Corporation, and is disclosed in U.S. Patent No. 5,360,402 to Conway et al.
  • Another device for preventing urine leakage is a valved catheter, which is left in the urethra for a period of time, typically for one month. During this time, voiding is accomplished by inserting a tube into the valve to allow urine to flow.
  • a valved catheter which is left in the urethra for a period of time, typically for one month. During this time, voiding is accomplished by inserting a tube into the valve to allow urine to flow.
  • a female incontinence device includes a body having an enlarged retention head at a first end, a removal portion or meatal anchor at a second end, and a water swellable ring of a gel forming material disposed about the body for securing the body within a female urethra and for preventing leakage between the body and the walls of the urethra.
  • the ring may be of a stimuli sensitive hydrophilic polymer which changes size in response to a stimuli.
  • a female incontinence device includes a tubular catheter body having an enlarged retention head at a first end thereof, a valve which prevents fluid from passing through the tubular catheter body, and a water swellable ring disposed about the tubular catheter body for securing and sealing the catheter body within a female urethra.
  • FIG. la is a side view of a valved catheter for female urinary incontinence according to a first embodiment of the present invention, with a swellable portion in an unswollen state;
  • FIG. lb is a side view of the catheter of FIG. la with the swellable portion in a swollen state;
  • FIG. 2 is a side sectional view of the catheter according to FIGS, la and
  • FIG. 3a is a side view of a valved catheter for female urinary incontinence according to a second embodiment of the present invention, with the swellable portion in an unswollen state;
  • FIG. 3b is a side view of the catheter of FIG. 2a with the swellable portion in a swollen state;
  • FIG. 4 is a side sectional view of the catheter according to FIGS. 3a and 3b, positioned within a urethra;
  • FIG. 5 is a perspective view of a urethral plug according to the present invention.
  • FIG. 6a is a side sectional view of a portion of a valved catheter for female urinary incontinence according to a third embodiment of the invention, with the swellable portion in an unswollen state;
  • FIG. 6b is a side sectional view of the catheter of FIG. 6a with the swellable portion in a swollen state.
  • the present invention offers a way to improve the performance of the types of known valved catheter and plug devices described above.
  • the invention utilizes one or more swellable ring sections mounted on a plug or catheter. The ring sections swell upon insertion to non-traumatically secure the device in the urethra.
  • a valved catheter body 10 includes a narrow band 20 of water swellable hydrophilic polymer which forms a gel when contacted with water.
  • the polymer can be a hydrophilic aliphatic polyurethane.
  • a suitable water swellable hydrophilic polymer is manufactured by Beverly Technologies of Dayton, NJ and sold under the name "HYPAN HYDROGEL".
  • the band 20 shown in FIG. la is a thin ring in the unswollen state and, as shown in FIG. lb, the band 20 is generally donut shaped in the swollen condition with rounded atraumatic edges.
  • the catheter 10 of FIG. la includes a one-way valve 12, such as a duck ⁇ bill valve, at one end thereof and an enlarged retention head 14 at an opposite end.
  • a one-way valve 12 such as a duck ⁇ bill valve
  • the retention head 14 includes apertures 16 which allow urine to flow into the interior of the catheter.
  • the retention head 14 is preferably of the type which may be elongated for insertion by passing a rigid member through the valve 12 and up though the catheter body 10 to elongate the retention head along the axis of the catheter. This elongation reduces the diameter of the retention head 14 for insertion or removal.
  • the catheter 10 is inserted into the urethra with the band 20 of water swellable material in the unswollen state.
  • the hydrophilic material forms a gel in the swollen state, as shown in FIG. 2.
  • the swollen band 20 takes up any free space that may exist between the catheter body 10 and the urethra 22, and gently forms a seal which prevents leakage between the exterior of the catheter and the urethra. Due to the soft, yielding nature of the gel, the catheter body 10 can be gently withdrawn without any trauma to the urethra 22.
  • FIGS. 3a, 3b, and 4 Another embodiment of the present invention, illustrated in FIGS. 3a, 3b, and 4, includes a cone shaped ring of hydrophilic material 40 surrounding the valved catheter body 10.
  • the cone 40 is designed to fit in the region of the bladder neck 42 typically immediately beneath the retention head 14 of the catheter. Upon swelling, the cone shaped ring 40 of this embodiment tends to exert a gentle force on the bladder neck 42 tending to maintain the retention head 14 of the catheter body 10 in the bladder 44. The ring 40 thus aids in overcoming the tendency of the bladder neck to expel the device from the urethra 22.
  • a plug type device 50 includes a shaft 52, a plate 54, and a solid ball, hollow ball or inflatable retention head 56.
  • the plug 50 incorporates at least one hydrophilic ring 58 in the shape of either a band 58 as shown or a cone (not shown).
  • the hydrophilic ring 58 helps to seal and retain the plug in the urethra.
  • the plug 50 having the swellable band 58 is completely removed from the urethra when the patient wishes to void.
  • the retention head 56 of the plug 50 may also be made of a hydrophilic material.
  • the configurations described above are designed such that the catheters and plugs can be withdrawn without difficulty with the swellable bands 20 or cones 40 in the swollen state.
  • the material used for the band or cone can be based on a stimuli sensitive polymer.
  • Known stimuli sensitive polymers include those which undergo a phase change which substantially alters the swelling characteristics of the material in response to a stimuli. Suitable stimuli include pH change, electrical field, mechanical stress, temperature, solvent interaction, light or combinations thereof.
  • a light sensitive material such as a N-isopropylacrylamide-chlorophyllin gel
  • a fiber optic light guide 62 transmits light to the ring of light sensitive gel 60.
  • Light emitted from a light source is applied to an exterior end of the light guide 62.
  • the light transmitted through the light guide 62 causes the gel ring 60 to undergo a phase change and reduce in volume for insertion or removal of the catheter 10.
  • the light source is removed from the light guide 62 and the gel undergoes a reverse phase change and reverts to the swollen configuration shown in FIG. 6b.
  • the catheter body 10 itself may also be used as a light guide, when made from a light transmitting material.
  • the gel ring 60 is preferably surrounded by a porous protective elastomeric layer 64.
  • the protective layer 64 allows urine to pass through the protective layer into the gel as the gel swells, and to pass out of the gel when the gel shrinks upon application of a light source.
  • one electrically sensitive material which undergoes a rapid electrically induced phase change is cross-linked sodium salt of polyacrylic acid.
  • Numerous other systems are known, and would be applicable to the present invention, such as systems incorporating materials which are sensitive to pH, temperature, or a solvent.
  • pH and temperature sensitive materials are somewhat less desirable than light and electrically sensitive materials because the body is subject to temperature and pH changes which may affect such a material.
  • Other methods of activation of the swellable material will be apparent to those skilled in the art.
  • the response times of stimuli sensitive materials are largely dependent on the rate at which water can enter or exude from the material. Response times can be reduced by employing open cell foam structures, or bundles of micro tubes or fibers, which are contained in a suitable porous elastic casing.
  • Light, heat, or electrical stimulation offer the most readily controllable stimuli for utilization in the devices of the present invention.
  • small, resistive heaters such as vapor deposited resistive heaters, can be used, in connection with an external power source.
  • valve of the valved catheter mentioned above with respect to the embodiments of FIGS. 1-4 can be replaced by a stimuli sensitive valve, e.g., a light stimulated sphincter of gel forming material, situated within the lumen of the device.
  • a stimuli sensitive valve e.g., a light stimulated sphincter of gel forming material
  • Light can be delivered to such a sphincter via embedded fiber optics or by the catheter itself wherever it is desired to shrink the gel forming material.
  • the retention mechanism or retention head in the catheters and plugs discussed above can also be replaced with a swellable retention head of gel forming material.

Abstract

A female incontinence device according to the present invention includes one or more rings of water swellable gel forming material (40) mounted on a female incontinence plug or catheter (10). The water swellable ring (40) swells upon insertion of the device into the urethra (22) and non-traumatically secures the device in the urethra (22) while providing a seal between the device and the walls of the urethra (22). The water swellable ring (40) may be replaced by other stimuli sensitive materials which allow the ring to be swollen and later reduced in volume for removal of the device. The stimuli sensitive materials which may be used in the invention include materials sensitive to light, pH, electrical field, mechanical stress, temperature, and solvent interaction.

Description

FEMALE INCONTINENCE DEVICE
Field of the Invention
The present invention relates to an improved device for controlling leakage of urine in an incontinent female, and more particularly, to valved catheters and plugs for use in controlling female incontinence.
Description of the Related Art
The urinary tract system aids the body in ridding itself of waste. The kidneys process blood at a high rate and filter waste products from the circulatory system, creating urine to remove the waste. The ureters drain urine from the kidneys into the bladder, which serves as a reservoir until urination.
The bladder has a storage capacity which ranges from approximately one-quarter to one-half liter. The urinary sphincter is a muscle at the base of the bladder which surrounds the bladder neck and urethra and aids the bladder in maintaining continence. The urethra is the tube through which urine flows when the bladder empties.
In the urinary tract, continence, or appropriate storage of urine, is maintained by a complex interplay of anatomic structures. In a normal system, the bladder neck and the urinary sphincter work in a coordinated fashion to act as a valve. During urination, the urethra and urinary sphincter muscles relax and open, the bladder contracts and the bladder neck opens, all in a coordinated fashion, causing the passage of urine. When the bladder neck opens involuntarily in response to intra-abdominal pressure, the lower portion of the urinary sphincter tightens in turn to maintain continence. Similarly, the urethra is also under muscular control to keep this tube closed during the urine storage phase.
A malfunction in any part of this system can cause urinary incontinence (UI) or loss of urine. The most common anatomic incontinence pathology is bladder neck or urethra hypermobility, which results from a lack of bladder neck support caused primarily by weak surrounding tissue. The weakening of tissue surrounding the bladder, urethra and bladder neck arises most commonly in women as a consequence of pelvic trauma caused by pregnancy and childbirth. Other causes of incontinence include physiological, anatomical and neurological disorders.
According to the U.S. Department of Heath and Human Services, there are approximately 10 million UI sufferers in the United States, of which it is estimated that approximately 85% are women. The total worldwide population suffering with UI for developed countries is approximately 22 million women. UI afflicts women of all ages, primarily those over 40, and tends to get worse over time. Women have short urethras and hence less occlusive force. More importantly, women suffer significant pelvic trauma during pregnancy and childbirth. In pregnancy and childbirth, a woman's pelvic nerves and muscles are stretched to a great degree and, as a result, the continence function is often impaired. Therefore, UI shows an increase in incidence as a function of the number of children born to a woman. Devices such as urinary plugs and catheters are used to prevent urine leakage in incontinent females. Urinary plugs generally are disposable devices. An example of such a device includes a shaft with one or two integral balls thereon. When inserted in the urethra the ball(s) occludes the urethra and holds the device in place until such time as the patient wishes to void, whereupon the plug is physically removed in order to allow urine to flow. Such a device is manufactured by PharmaPlast of Denmark. Another plug type device, manufactured by Uromed Corporation, uses an inflated balloon to retain the device in place. This type of device is disclosed in U.S. Patent No. 5,090,424 to Simon et al. and in WO94/26215 to McLaughlin et al. Another similar plug type device is manufactured by Rochester Medical Corporation, and is disclosed in U.S. Patent No. 5,360,402 to Conway et al.
Another device for preventing urine leakage is a valved catheter, which is left in the urethra for a period of time, typically for one month. During this time, voiding is accomplished by inserting a tube into the valve to allow urine to flow. Such a device is disclosed in U.S. Patent No. 5,352,182 to Kalb et al. Several problems are associated with the above described devices. Due to irritation of the bladder neck, it is not unusual for a bladder spasm to occur, which can expel the device. The devices are frequently somewhat traumatic, and erosion of the bladder neck is possible. Additionally, given the variety of shapes and sizes of the female urethra, a wide range of sizes of these devices may be needed in order to accommodate urethra of different lengths and diameters. This can lead to problems in correct device sizing, and inventory problems in manufacturing. Accordingly, there is a need in the art for a device which addresses these problems.
Summary of the Invention
The device according to the present invention addresses the disadvantages of the prior art incontinence devices. The invention offers improved performance over known incontinence devices and accommodates different urethra sizes with reduced trauma to the bladder neck. According to one aspect of the present invention a female incontinence device includes a body having an enlarged retention head at a first end, a removal portion or meatal anchor at a second end, and a water swellable ring of a gel forming material disposed about the body for securing the body within a female urethra and for preventing leakage between the body and the walls of the urethra. The ring may be of a stimuli sensitive hydrophilic polymer which changes size in response to a stimuli.
According to another aspect of the present invention a female incontinence device includes a tubular catheter body having an enlarged retention head at a first end thereof, a valve which prevents fluid from passing through the tubular catheter body, and a water swellable ring disposed about the tubular catheter body for securing and sealing the catheter body within a female urethra. Brief Description of the Drawings
The invention will be described in greater detail with reference to the accompanying drawings in which like elements bear like reference numerals, and wherein: FIG. la is a side view of a valved catheter for female urinary incontinence according to a first embodiment of the present invention, with a swellable portion in an unswollen state;
FIG. lb is a side view of the catheter of FIG. la with the swellable portion in a swollen state; FIG. 2 is a side sectional view of the catheter according to FIGS, la and
1 b, positioned within a urethra;
FIG. 3a is a side view of a valved catheter for female urinary incontinence according to a second embodiment of the present invention, with the swellable portion in an unswollen state; FIG. 3b is a side view of the catheter of FIG. 2a with the swellable portion in a swollen state;
FIG. 4 is a side sectional view of the catheter according to FIGS. 3a and 3b, positioned within a urethra;
FIG. 5 is a perspective view of a urethral plug according to the present invention;
FIG. 6a is a side sectional view of a portion of a valved catheter for female urinary incontinence according to a third embodiment of the invention, with the swellable portion in an unswollen state; and
FIG. 6b is a side sectional view of the catheter of FIG. 6a with the swellable portion in a swollen state.
Detailed Description of the Preferred Embodiments
The present invention offers a way to improve the performance of the types of known valved catheter and plug devices described above. The invention utilizes one or more swellable ring sections mounted on a plug or catheter. The ring sections swell upon insertion to non-traumatically secure the device in the urethra.
According to the embodiment of the device shown in FIGS, la, lb, and 2, a valved catheter body 10 includes a narrow band 20 of water swellable hydrophilic polymer which forms a gel when contacted with water. For instance, the polymer can be a hydrophilic aliphatic polyurethane. A suitable water swellable hydrophilic polymer is manufactured by Kingston Technologies of Dayton, NJ and sold under the name "HYPAN HYDROGEL". The band 20 shown in FIG. la is a thin ring in the unswollen state and, as shown in FIG. lb, the band 20 is generally donut shaped in the swollen condition with rounded atraumatic edges.
The catheter 10 of FIG. la includes a one-way valve 12, such as a duck¬ bill valve, at one end thereof and an enlarged retention head 14 at an opposite end. Although the valve 12 is shown as located at an end of the catheter, it may be positioned at other locations within the catheter. The retention head 14 includes apertures 16 which allow urine to flow into the interior of the catheter. The retention head 14 is preferably of the type which may be elongated for insertion by passing a rigid member through the valve 12 and up though the catheter body 10 to elongate the retention head along the axis of the catheter. This elongation reduces the diameter of the retention head 14 for insertion or removal.
In operation, the catheter 10 is inserted into the urethra with the band 20 of water swellable material in the unswollen state. Upon exposure to urine, the hydrophilic material forms a gel in the swollen state, as shown in FIG. 2. The swollen band 20 takes up any free space that may exist between the catheter body 10 and the urethra 22, and gently forms a seal which prevents leakage between the exterior of the catheter and the urethra. Due to the soft, yielding nature of the gel, the catheter body 10 can be gently withdrawn without any trauma to the urethra 22. Due to the tendency for the urethra to relax locally over time it is advantageous to the patient to alternate the position of the swellable band 20 from one use to the next, thus minimizing the length of time any particular portion of the urethra is dilated.
Another embodiment of the present invention, illustrated in FIGS. 3a, 3b, and 4, includes a cone shaped ring of hydrophilic material 40 surrounding the valved catheter body 10. The cone 40 is designed to fit in the region of the bladder neck 42 typically immediately beneath the retention head 14 of the catheter. Upon swelling, the cone shaped ring 40 of this embodiment tends to exert a gentle force on the bladder neck 42 tending to maintain the retention head 14 of the catheter body 10 in the bladder 44. The ring 40 thus aids in overcoming the tendency of the bladder neck to expel the device from the urethra 22.
A catheter body including a combination of a first section with a band 20 and a second section with a cone 40 may optimize results somewhat by providing the benefits of each of these swellable sections. According to a third embodiment of the present invention, as illustrated in FIG. 5, a plug type device 50 includes a shaft 52, a plate 54, and a solid ball, hollow ball or inflatable retention head 56. The plug 50 incorporates at least one hydrophilic ring 58 in the shape of either a band 58 as shown or a cone (not shown). The hydrophilic ring 58 helps to seal and retain the plug in the urethra. According to the embodiment of FIG. 5, the plug 50 having the swellable band 58 is completely removed from the urethra when the patient wishes to void. The retention head 56 of the plug 50 may also be made of a hydrophilic material.
In most instances the configurations described above are designed such that the catheters and plugs can be withdrawn without difficulty with the swellable bands 20 or cones 40 in the swollen state. However, there may be instances where, due to the need for a particularly large occluding section, it would be convenient to reverse the swelling of the material to facilitate easier removal. In this instance, the material used for the band or cone can be based on a stimuli sensitive polymer. Known stimuli sensitive polymers include those which undergo a phase change which substantially alters the swelling characteristics of the material in response to a stimuli. Suitable stimuli include pH change, electrical field, mechanical stress, temperature, solvent interaction, light or combinations thereof.
According to the embodiment shown in FIGS. 6a and 6b, a light sensitive material such as a N-isopropylacrylamide-chlorophyllin gel, is formed in the shape of a ring 60 around a catheter 10. In the embodiment shown, the material has been exposed to water and thus is in a swollen gel state. The application of light to the light sensitive gel will cause a phase change and reduction in the volume of the gel. As shown in FIG. 6a, a fiber optic light guide 62 transmits light to the ring of light sensitive gel 60. Light emitted from a light source is applied to an exterior end of the light guide 62. The light transmitted through the light guide 62 causes the gel ring 60 to undergo a phase change and reduce in volume for insertion or removal of the catheter 10. Once the catheter has been inserted, the light source is removed from the light guide 62 and the gel undergoes a reverse phase change and reverts to the swollen configuration shown in FIG. 6b.
Although this embodiment of the invention has been described as employing a separate fiber optic light guide 62, the catheter body 10 itself may also be used as a light guide, when made from a light transmitting material. As shown in FIGS. 6a and 6b, the gel ring 60 is preferably surrounded by a porous protective elastomeric layer 64. The protective layer 64 allows urine to pass through the protective layer into the gel as the gel swells, and to pass out of the gel when the gel shrinks upon application of a light source.
Other known stimuli sensitive materials which are suitable for use in the present invention include electrically sensitive materials. For example, one electrically sensitive material which undergoes a rapid electrically induced phase change is cross-linked sodium salt of polyacrylic acid. Numerous other systems are known, and would be applicable to the present invention, such as systems incorporating materials which are sensitive to pH, temperature, or a solvent. However, pH and temperature sensitive materials are somewhat less desirable than light and electrically sensitive materials because the body is subject to temperature and pH changes which may affect such a material. Other methods of activation of the swellable material will be apparent to those skilled in the art.
The response times of stimuli sensitive materials are largely dependent on the rate at which water can enter or exude from the material. Response times can be reduced by employing open cell foam structures, or bundles of micro tubes or fibers, which are contained in a suitable porous elastic casing. Light, heat, or electrical stimulation offer the most readily controllable stimuli for utilization in the devices of the present invention. For temperature based phase changes, small, resistive heaters, such as vapor deposited resistive heaters, can be used, in connection with an external power source.
In yet a further embodiment of the device, the valve of the valved catheter mentioned above with respect to the embodiments of FIGS. 1-4 can be replaced by a stimuli sensitive valve, e.g., a light stimulated sphincter of gel forming material, situated within the lumen of the device. Light can be delivered to such a sphincter via embedded fiber optics or by the catheter itself wherever it is desired to shrink the gel forming material. The retention mechanism or retention head in the catheters and plugs discussed above can also be replaced with a swellable retention head of gel forming material. While the invention has been described in detail with reference to a preferred embodiment thereof, it will be apparent to one skilled in the art that various changes can be made, and equivalents employed without departing from the spirit and scope of the invention.

Claims

WHAT IS CLAIMED IS:
1. A female incontinence device comprising: a body having an enlarged retention head at a first end and a removal or meatal anchor portion at a second end; and at least one water swellable ring of a gel forming material disposed about the body for preventing leakage between the body and walls of the urethra.
2. The female incontinence device according to Claim 1 , wherein the gel forming material swells when it comes into contact with urine.
3. The female incontinence device according to Claim 2, wherein the gel forming material is a hydrophilic polymer.
4. The female incontinence device according to Claim 1, wherein the gel forming material swells to a predetermined size small enough to allow the device to be removed without causing trauma to the urethra.
5. The female incontinence device according to Claim 1 , comprising a plurality of rings of the gel forming material, the rings being spaced apart and providing a seal between the body and the walls of the urethra when the rings are in a swollen state.
6. The female incontinence device according to Claim 1 , wherein the ring is the retention head.
7. The female incontinence device according to Claim 1 , wherein the ring comprises a conical ring which increases in diameter in a direction away from first end.
8. The female incontinence device according to Claim 1 , wherein the ring is formed of a stimuli sensitive polymer which undergoes a phase change and changes size in response to a stimuli.
9. The female incontinence device according to Claim 8, wherein the stimuli is selected from the group consisting of light, pH, electrical field, mechanical stress, temperature, and solvent interaction.
10. The female incontinence device according to Claim 1 , wherein the retention head includes at least one opening and the body is a tubular catheter having a valve which prevents fluid from passing from the retention head, through a lumen of the catheter and outwardly of the removal or meatal anchor portion.
1 1. The female incontinence device according to Claim 1 , wherein the body is a sealing plug which prevents passage of urine and is removable to allow a flow of urine.
12. The female incontinence device according to Claim 1 , wherein the enlarged retention head is expandable to retain the device in the urethra.
13. A female incontinence device comprising: a tubular catheter body having an enlarged retention head at a first end thereof and a valve which prevents fluid from passing through the tubular catheter body; and at least one water swellable ring of a gel forming material disposed about the tubular catheter body for sealing the catheter body within a female urethra.
14. The female incontinence device according to Claim 13, wherein the gel forming material is a water swellable hydrophilic polymer which swells when it comes into contact with urine.
15. The female incontinence device according to Claim 13, comprising a plurality of rings of the gel forming material, the rings being spaced apart and providing a seal between the body and the walls of the urethra when the rings are in a swollen state.
16. The female incontinence device according to Claim 13, wherein the ring has a conical shape in a swollen state.
17. The female incontinence device according to Claim 13, wherein the ring is formed of a stimuli sensitive polymer which undergoes a phase change and changes size in response to a stimuli.
18. The female incontinence device according to Claim 17, wherein the stimuli is selected from the group consisting of light, pH, electrical field, mechanical stress, temperature, and solvent interaction.
19. A female incontinence catheter comprising: a tubular catheter body having an enlarged retention head at a first end thereof; and a water swellable valve of a gel forming material positioned within the catheter which prevents fluid from passing through the tubular catheter body, the gel forming material being of a stimuli sensitive polymer which undergoes a phase change and changes size in response to a stimuli.
20. The female incontinence device according to Claim 19, wherein the stimuli is selected from the group consisting of light, pH, electrical field, mechanical stress, temperature, and solvent interaction.
21. The female incontinence device according to Claim 19, further comprising at least one water swellable ring of a gel forming material disposed about the body for preventing leakage between the body and walls of the urethra.
22. The female incontinence device according to Claim 19, wherein the gel forming material is a water swellable hydrophilic polymer which swells when it comes into contact with urine.
23. The female incontinence device according to Claim 22, further comprising a plurality of rings of the gel forming material, the rings being spaced apart and providing a seal between the body and the walls of the urethra when the rings are in a swollen state.
PCT/US1997/003401 1996-03-05 1997-03-05 Female incontinence device WO1997032542A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/610,866 1996-03-05
US08/610,866 US5722931A (en) 1996-03-05 1996-03-05 Female incontinence device

Publications (1)

Publication Number Publication Date
WO1997032542A1 true WO1997032542A1 (en) 1997-09-12

Family

ID=24446737

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/003401 WO1997032542A1 (en) 1996-03-05 1997-03-05 Female incontinence device

Country Status (2)

Country Link
US (1) US5722931A (en)
WO (1) WO1997032542A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000151A1 (en) * 1998-06-29 2000-01-06 The Procter & Gamble Company Disposable absorbent article having a responsive system including an electrical actuator
WO2000000148A1 (en) * 1998-06-29 2000-01-06 The Procter & Gamble Company Disposable treatment article having a responsive system
WO2000000150A1 (en) * 1998-06-29 2000-01-06 The Procter & Gamble Company Disposable absorbant article having a responsive system including a feedback control loop
WO2000000137A3 (en) * 1998-06-29 2000-04-13 Procter & Gamble Disposable article having bodily waste isolation device
US6149636A (en) * 1998-06-29 2000-11-21 The Procter & Gamble Company Disposable article having proactive sensors
US6160198A (en) * 1998-06-29 2000-12-12 The Procter & Gamble Company Disposable article having a discontinuous responsive system
US6186991B1 (en) 1998-06-29 2001-02-13 The Procter & Gamble Company Disposable article having a responsive system including a mechanical actuator
US6311689B1 (en) 2000-03-10 2001-11-06 Conticare Medical, Inc. Female incontinence prevention device
US6359190B1 (en) 1998-06-29 2002-03-19 The Procter & Gamble Company Device for measuring the volume of a body cavity
US6372951B1 (en) 1998-06-29 2002-04-16 The Procter & Gamble Company Disposable article having sensor to detect impending elimination of bodily waste
US6407308B1 (en) 1998-06-29 2002-06-18 The Procter & Gamble Company Disposable article having sensor to detect impending elimination of bodily waste
US6433244B1 (en) 1998-06-29 2002-08-13 The Procter & Gamble Company Disposable treatment article having a responsive system
US8981177B2 (en) 1997-11-14 2015-03-17 The Procter & Gamble Company Disposable article providing improved management of bodily exudates

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056687A (en) * 1997-12-04 2000-05-02 American Medical Systems, Inc. Device for alleviating urinary incontinence
US6200261B1 (en) 1998-03-04 2001-03-13 American Medical Systems, Inc. Valve and methods for urinary control
US6030337A (en) * 1998-07-30 2000-02-29 American Medical Systems, Inc. Continence augmentor and methods for urinary control
US6503190B1 (en) * 2000-09-29 2003-01-07 Ethicon Endo-Surgery, Inc. Vaginal pessary
CA2451826A1 (en) * 2001-06-29 2003-01-09 Ethicon, Inc. System for assessing urinary function
US7004899B2 (en) 2001-06-29 2006-02-28 Ethicon, Inc. System and method for assessing urinary function
US6739341B2 (en) * 2002-05-15 2004-05-25 Conticare Medical, Inc. Incontinence device insertion kit
US20050099294A1 (en) * 2003-08-05 2005-05-12 Bogner James T. System for managing conditions
EP2085049B1 (en) * 2003-08-11 2019-06-19 Cook Medical Technologies LLC Surgical implant with penetrating tip
US6976542B2 (en) * 2003-10-03 2005-12-20 Baker Hughes Incorporated Mud flow back valve
US8217219B2 (en) 2003-12-29 2012-07-10 Kimberly-Clark Worldwide, Inc. Anatomically conforming vaginal insert
US20070295337A1 (en) * 2006-06-22 2007-12-27 Nelson Donald S Endotracheal cuff and technique for using the same
US8434487B2 (en) 2006-06-22 2013-05-07 Covidien Lp Endotracheal cuff and technique for using the same
US8196584B2 (en) 2006-06-22 2012-06-12 Nellcor Puritan Bennett Llc Endotracheal cuff and technique for using the same
US20070296125A1 (en) * 2006-06-22 2007-12-27 Joel Colburn Thin cuff for use with medical tubing and method and apparatus for making the same
US20080053454A1 (en) * 2006-09-01 2008-03-06 Nellcor Puritan Bennett Incorporated Endotracheal tube including a partially inverted cuff collar
US8684175B2 (en) 2006-09-22 2014-04-01 Covidien Lp Method for shipping and protecting an endotracheal tube with an inflated cuff
US8561614B2 (en) * 2006-09-28 2013-10-22 Covidien Lp Multi-layer cuffs for medical devices
US20080078405A1 (en) * 2006-09-29 2008-04-03 Crumback Gary L Self-sizing adjustable endotracheal tube
US20080078399A1 (en) 2006-09-29 2008-04-03 O'neil Michael P Self-sizing adjustable endotracheal tube
US20080078401A1 (en) * 2006-09-29 2008-04-03 Nellcor Puritan Bennett Incorporated Self-sizing adjustable endotracheal tube
US7950393B2 (en) * 2006-09-29 2011-05-31 Nellcor Puritan Bennett Llc Endotracheal cuff and technique for using the same
US8807136B2 (en) * 2006-09-29 2014-08-19 Covidien Lp Self-sizing adjustable endotracheal tube
US8307830B2 (en) 2006-09-29 2012-11-13 Nellcor Puritan Bennett Llc Endotracheal cuff and technique for using the same
US20080215034A1 (en) * 2007-03-02 2008-09-04 Jessica Clayton Endotracheal cuff and technique for using the same
US20080210243A1 (en) * 2007-03-02 2008-09-04 Jessica Clayton Endotracheal cuff and technique for using the same
US8750978B2 (en) * 2007-12-31 2014-06-10 Covidien Lp System and sensor for early detection of shock or perfusion failure and technique for using the same
US20090326490A1 (en) * 2008-06-30 2009-12-31 Mcmichael Donald Jay Fecal incontinence collection device and method of use
USD695403S1 (en) * 2008-11-05 2013-12-10 Renew Medical Inc. Anal plug
USD767132S1 (en) * 2008-11-05 2016-09-20 Renew Medical Inc. Transparent anal plug
US8590534B2 (en) * 2009-06-22 2013-11-26 Covidien Lp Cuff for use with medical tubing and method and apparatus for making the same
US20120238802A1 (en) * 2011-03-15 2012-09-20 Joseph Allen Knight Short-term device for the treatment of urinary incontinence in women
US9364306B2 (en) * 2011-09-12 2016-06-14 Boston Scientific Scimed, Inc. Implantable medical device and method of placement of the implantable medical device
US20130079589A1 (en) * 2011-09-22 2013-03-28 Coloplast A/S Incontinence treatment device configured for urethral placement into the bladder
USD754343S1 (en) * 2012-06-03 2016-04-19 Renew Medical, Inc. Transparent anal plug
USD753825S1 (en) * 2012-06-03 2016-04-12 Renew Medical, Inc. Transparent anal plug
USD691262S1 (en) * 2012-06-03 2013-10-08 Renew Medical Inc. Anal plug
EP2749308B1 (en) 2012-12-28 2016-04-27 Cook Medical Technologies LLC Hollow fiber ureteral stent
USD754342S1 (en) * 2015-02-23 2016-04-19 Renew Medical, Inc. Anal plug
USD835784S1 (en) * 2017-07-25 2018-12-11 Life360 Innovations Inc. Urethral plug
US10441396B2 (en) * 2017-08-22 2019-10-15 Life360 Innovations Inc. Urethral plug and system for addressing urinary incontinence

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172066A (en) * 1974-06-21 1979-10-23 The Dow Chemical Company Cross-linked, water-swellable polymer microgels
US5148825A (en) * 1991-11-20 1992-09-22 Plastro-Gvat Moisture-responsive valve
US5476434A (en) * 1992-05-27 1995-12-19 Kalb; Irvin M. Female incontinence device including electronic sensors
US5509427A (en) * 1990-12-31 1996-04-23 Uromed Corporation Urethral plug assembly having adhesive for enhanced sealing capabilities and method of using said plug assembly
US5520672A (en) * 1991-04-19 1996-05-28 Urry; Dan W. Superabsorbent materials and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360402A (en) * 1990-01-10 1994-11-01 Rochester Medical Corporation Hand-actuated retention catheter
US5090424A (en) * 1990-12-31 1992-02-25 Uromed Corporation Conformable urethral plug
US5352182A (en) * 1992-05-27 1994-10-04 Kalb Irvin M Product and method to treat female incontinence
EP0699060A4 (en) * 1993-05-17 1997-05-21 Uromed Corp Expandable urethral plug

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172066A (en) * 1974-06-21 1979-10-23 The Dow Chemical Company Cross-linked, water-swellable polymer microgels
US5509427A (en) * 1990-12-31 1996-04-23 Uromed Corporation Urethral plug assembly having adhesive for enhanced sealing capabilities and method of using said plug assembly
US5520672A (en) * 1991-04-19 1996-05-28 Urry; Dan W. Superabsorbent materials and uses thereof
US5148825A (en) * 1991-11-20 1992-09-22 Plastro-Gvat Moisture-responsive valve
US5476434A (en) * 1992-05-27 1995-12-19 Kalb; Irvin M. Female incontinence device including electronic sensors

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8981177B2 (en) 1997-11-14 2015-03-17 The Procter & Gamble Company Disposable article providing improved management of bodily exudates
US6359190B1 (en) 1998-06-29 2002-03-19 The Procter & Gamble Company Device for measuring the volume of a body cavity
JP2002519110A (en) * 1998-06-29 2002-07-02 ザ、プロクター、エンド、ギャンブル、カンパニー Disposable absorber with reaction system including electric actuator
WO2000000137A3 (en) * 1998-06-29 2000-04-13 Procter & Gamble Disposable article having bodily waste isolation device
US6093869A (en) * 1998-06-29 2000-07-25 The Procter & Gamble Company Disposable article having a responsive system including a feedback control loop
US6149636A (en) * 1998-06-29 2000-11-21 The Procter & Gamble Company Disposable article having proactive sensors
US6160198A (en) * 1998-06-29 2000-12-12 The Procter & Gamble Company Disposable article having a discontinuous responsive system
US6186991B1 (en) 1998-06-29 2001-02-13 The Procter & Gamble Company Disposable article having a responsive system including a mechanical actuator
US6372951B1 (en) 1998-06-29 2002-04-16 The Procter & Gamble Company Disposable article having sensor to detect impending elimination of bodily waste
WO2000000148A1 (en) * 1998-06-29 2000-01-06 The Procter & Gamble Company Disposable treatment article having a responsive system
JP4727040B2 (en) * 1998-06-29 2011-07-20 ザ プロクター アンド ギャンブル カンパニー Disposable products
US6266557B1 (en) 1998-06-29 2001-07-24 The Procter & Gamble Company Biofeedback device for an incontinent person
US6384296B1 (en) 1998-06-29 2002-05-07 The Procter & Gamble Company Disposable article having a responsive system including an electrical actuator
US6407308B1 (en) 1998-06-29 2002-06-18 The Procter & Gamble Company Disposable article having sensor to detect impending elimination of bodily waste
WO2000000150A1 (en) * 1998-06-29 2000-01-06 The Procter & Gamble Company Disposable absorbant article having a responsive system including a feedback control loop
US6423044B1 (en) 1998-06-29 2002-07-23 The Procter & Gamble Company Disposable article having bodily waste isolation device
US6433244B1 (en) 1998-06-29 2002-08-13 The Procter & Gamble Company Disposable treatment article having a responsive system
US6570053B2 (en) 1998-06-29 2003-05-27 The Procter & Gamble Company Disposable article having a proactive sensor
WO2000000151A1 (en) * 1998-06-29 2000-01-06 The Procter & Gamble Company Disposable absorbent article having a responsive system including an electrical actuator
USRE39626E1 (en) * 2000-03-10 2007-05-15 Consert, Llc Female incontinence prevention device
US6311689B1 (en) 2000-03-10 2001-11-06 Conticare Medical, Inc. Female incontinence prevention device

Also Published As

Publication number Publication date
US5722931A (en) 1998-03-03

Similar Documents

Publication Publication Date Title
US5722931A (en) Female incontinence device
AU577823B2 (en) Elastomeric prosthetic sphincter
US7041139B2 (en) Ureteral stents and related methods
US5989288A (en) Device for maintaining urinary continence
US5234409A (en) Female incontinence control device and method
US7771344B2 (en) Device for the prevention of urinary incontinence in females
US6231501B1 (en) Urinary occlusion device
US20090125120A1 (en) Drainage Devices
AU2701695A (en) Female anti-incontinence device
EP1392388A2 (en) Endourethral device & method
WO1990004431A1 (en) Incontinence device
US6311689B1 (en) Female incontinence prevention device
CA2401081C (en) Method and device for intra-urethral incontinence
US6558312B2 (en) Intraurethral device for incontinence
CA2301904C (en) Nonsurgical intraurethral bladder control device retainer
CN113499531A (en) Safe urine-leakage-proof washing catheter
CN216986023U (en) Safe urine-leakage-proof washing catheter
NZ210804A (en) Elastomeric prosthetic sphincter
AU2002235470A1 (en) Endourethral device & method

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase